Ligustroside (Ligstroside), a secoiridoid derivative, has outstanding performance on mitochondrial bioenergetics in models of early Alzheimer's disease (AD) and brain ageing by mechanisms that may not interfere with Aβ production. Ligustroside significantly inhibits nitric oxide production in lipopolysaccharide-activated RAW264.7 macrophages. In Vitro Ligstroside increases mRNA expression of SIRT1, CREB1, complex I, and GPx1 in SH-SY5Y-APP 695 cells. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo Ligstroside (50 mg/kg; a supplemented diet for 6 months) protects against mitochondrial dysfunction in models of early Alzheimer's disease and brain ageing . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Female NMRI mice, aged 12 months Dosage: 50 mg/kg Administration: Received a supplemented diet for 6 months (equivalent to 6.25 mg/kg b.w.) Result: Showed improved spatial working memory; Restored brain ATP levels in aged mice and led to a significant life extension compared to aged control animals. Form:Solid
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Ligustroside
CAS number：35897-92-8 molecular formula：C25H32O12
overview
compound introduction
Specs
| Chinese alias | 女贞子苷 | ||
| English alias | 83S9SA69C5 | Q27269447 | CHEBI:149585 | MS-29709 | 2H-PYRAN-4-ACETIC ACID, 3-ETHYLIDENE-2-(.BETA.-D-GLUCOPYRANOSYLOXY)-3,4-DIHYDRO-5-(METHOXYCARBONYL)-, 2-(4-HYDROXYPHENYL)ETHYL ESTER, (2S,3E,4S)- | AKOS040760521 | DTXSID701318124 | methyl (4S,5E,6S)-5-et | ||
| CAS number | 35897-92-8 | molecular formula | C25H32O12 |
| molecular weight | 524.51 g/mol | Exact mass | ≥98% |
| PSA | 181.000 Ų | logp | -0.100 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 1 shareMSDS
35897-92-8|Ligstroside Nitric oxide inhibitor, ≥95%|Ligstroside Nitric oxide inhibitor, ≥95%
